Mr. Chair, I have to clarify. It improves the global supply, ultimately.
By “efficiency” I was not referring to the performance of the vaccine. That has no change whatsoever with moving from five to six. What does change is that the amount of vaccine that can be provided from a given production lot becomes increased. Ultimately, the amount of supply available to all becomes enhanced. The amount of supply that's available to Canada remains what we have contracted—